Streinu-Cercel, A.; Miron, V.D.; Oană, A.A.; Irimia, M.; Popescu, R.Ș.; Dărămuș, I.A.; Moțoi, M.M.; Ceapraga, G.J.; Săndulescu, O.
Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection—A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center. Pharmaceuticals 2022, 15, 1065.
https://doi.org/10.3390/ph15091065
AMA Style
Streinu-Cercel A, Miron VD, Oană AA, Irimia M, Popescu RȘ, Dărămuș IA, Moțoi MM, Ceapraga GJ, Săndulescu O.
Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection—A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center. Pharmaceuticals. 2022; 15(9):1065.
https://doi.org/10.3390/ph15091065
Chicago/Turabian Style
Streinu-Cercel, Anca, Victor Daniel Miron, Alina Alexandra Oană, Mădălina Irimia, Ramona Ștefania Popescu, Ioana Andreea Dărămuș, Maria Magdalena Moțoi, Gabriela Jana Ceapraga, and Oana Săndulescu.
2022. "Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection—A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center" Pharmaceuticals 15, no. 9: 1065.
https://doi.org/10.3390/ph15091065
APA Style
Streinu-Cercel, A., Miron, V. D., Oană, A. A., Irimia, M., Popescu, R. Ș., Dărămuș, I. A., Moțoi, M. M., Ceapraga, G. J., & Săndulescu, O.
(2022). Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection—A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center. Pharmaceuticals, 15(9), 1065.
https://doi.org/10.3390/ph15091065